Investing.com - Tff Pharma (NASDAQ: TFFP) reported third quarter EPS of $-0.0900, $0.03 better than the analyst estimate of $-0.1200. Revenue for the quarter came in at $234.76K versus the consensus estimate of $100K.
Tff Pharma's stock price closed at $0.2400. It is down -35.4800% in the last 3 months and down -80.1800% in the last 12 months.
Tff Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Tff Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Tff Pharma's Financial Health score is "fair performance".
Check out Tff Pharma's recent earnings performance, and Tff Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar